Article

CMS clears retinal prosthesis system for payments

Second Sight Medical Products Inc.’s retinal prosthesis system has been approved by the Centers for Medicare and Medicaid Services (CMS) for both inpatient and outpatient settings of care payments beginning Oct. 1.

Sylmar, CA-Second Sight Medical Products Inc.’s retinal prosthesis system has been approved by the Centers for Medicare and Medicaid Services (CMS) for both inpatient and outpatient settings of care payments beginning Oct. 1.

Cases involving the technology, Argus II, which are eligible for new technology add-on payments under the Medicare inpatient prospective payment system, will be identified by the new ICD-9-CM procedure code 14.81.

The payment will also be available to all hospital outpatient facilities and ambulatory surgical centers (ASCs) that perform the procedure for Medicare beneficiaries, and will be identified by the 0100T CPT code.

“We are excited that CMS recognizes that the (retinal prosthesis system) provides a substantial clinical benefit to patients and meets all of the criteria for both of these payments,” said Brian Mech, vice president of business development at Second Sight. “This news greatly facilitates access to the (technology) for Medicare beneficiaries regardless of the setting of care in which the system is provided.”

Guideline information on billing, coding, and payment for hospital outpatient departments and ASCs will be provided by CMS on or before Sept. 1.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.